Oral cannabinoid formulations
US10265293B2 · kind B2 · utility
1Cited by
4References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 19, 2016 |
| Grant date | Apr 23, 2019 |
| Priority date | — |
| Expiry date | Apr 19, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Oral cannabinoid formulations, including an aqueous-based oral dronabinol solution, that are stable at room or refrigerated temperatures and may possess improved in vivo absorption profiles with faster onset and lower inter-subject variability.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.